+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 190 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5893494
Free Webex Call
10% Free customization
Description Jump to:

Tablets & capsule is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Nutraceuticals CDMO Market, valued at USD 35.10 Billion in 2024, is projected to experience a CAGR of 7.90% to reach USD 55.39 Billion by 2030. Nutraceuticals are products derived from food sources that provide health benefits beyond basic nutrition, encompassing dietary supplements and functional foods. The global nutraceuticals Contract Development and Manufacturing Organization (CDMO) market experiences robust growth, primarily driven by increasing consumer awareness of preventative healthcare, an aging global population, and the escalating demand for specialized formulations and complex product development.

Key Market Drivers

The global nutraceutical CDMO market is experiencing substantial expansion, primarily driven by the escalating consumer demand for health and wellness products, alongside an increasing trend of outsourcing manufacturing and development within the nutraceutical sector. Consumers are proactively seeking dietary solutions that offer benefits beyond basic nutrition, a behavior pattern reflected in specific market segments. For instance, according to the International Probiotics Association, in March 2024, the Asia-Pacific region contributed USD 3.7 billion to global probiotic supplement sales in 2023, representing 42% of the total. This sustained demand for diverse and specialized nutraceuticals necessitates advanced manufacturing capabilities and formulation expertise many brands often lack internally.

Key Market Challenges

A significant challenge impeding the expansion of the Global Nutraceuticals CDMO Market is the stringent and constantly evolving global regulatory landscape. The necessity for CDMOs to continuously adapt and invest in compliance measures directly hampers market growth by increasing operational complexities and costs. This dynamic environment requires substantial resource allocation for staying abreast of diverse national and international regulations, including ingredient approvals, labeling requirements, and manufacturing standards.

Such continuous investment in regulatory expertise, quality systems, and facility upgrades to meet new guidelines leads to higher overheads, impacting pricing strategies and potentially reducing the competitiveness of CDMOs. For instance, according to the National Association of Manufacturers, in 2022, the average U. S. manufacturer paid over $29,000 per employee per year to comply with federal regulations, calculated in 2023 dollars. This financial burden elevates the barrier to entry for new CDMOs and poses an ongoing strain on existing players, thereby limiting overall market expansion as resources are diverted from innovation or capacity building towards compliance.

Key Market Trends

The increasing consumer demand for tailored health solutions is significantly driving the market through personalized nutrition and custom formulation capabilities. Nutraceutical CDMOs are adapting their development and manufacturing processes to produce bespoke products that cater to individual health profiles, genetic predispositions, and lifestyle choices. This shift necessitates flexible production lines, advanced ingredient sourcing, and expertise in diverse formulations to meet evolving consumer expectations for unique dietary support.

Key Market Players Profiled:

  • Catalent Inc.
  • Lonza Group AG
  • NUTRASCIENCE LABS Inc
  • Robinson Pharma, Inc.
  • Health Wright Products, Inc.
  • Innovations in Nutrition + Wellness
  • INPHARMA S.p.A.
  • Aenova Group
  • NutraPak USA
  • SFI Health Pty Ltd.

Report Scope:

In this report, the Global Nutraceuticals CDMO Market has been segmented into the following categories:

By Dosage Form:

  • Tablets & Capsules
  • Powder
  • Softgel
  • Others

By Service:

  • Product Formulation and Development
  • Manufacturing and Packaging
  • Research & Development (R&D)
  • Regulatory Compliance
  • Others

By Company Size:

  • Small Companies
  • Mid-Sized Companies
  • Large Companies

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nutraceuticals CDMO Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Nutraceuticals CDMO Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Dosage Form (Tablets & Capsules, Powder, Softgel, Others)
5.2.2. By Service (Product Formulation and Development, Manufacturing and Packaging, Research & Development (R&D), Regulatory Compliance, Others)
5.2.3. By Company Size (Small Companies, Mid-Sized Companies, Large Companies)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Nutraceuticals CDMO Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Dosage Form
6.2.2. By Service
6.2.3. By Company Size
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Nutraceuticals CDMO Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Dosage Form
6.3.1.2.2. By Service
6.3.1.2.3. By Company Size
6.3.2. Canada Nutraceuticals CDMO Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Dosage Form
6.3.2.2.2. By Service
6.3.2.2.3. By Company Size
6.3.3. Mexico Nutraceuticals CDMO Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Dosage Form
6.3.3.2.2. By Service
6.3.3.2.3. By Company Size
7. Europe Nutraceuticals CDMO Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Dosage Form
7.2.2. By Service
7.2.3. By Company Size
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Nutraceuticals CDMO Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Dosage Form
7.3.1.2.2. By Service
7.3.1.2.3. By Company Size
7.3.2. France Nutraceuticals CDMO Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Dosage Form
7.3.2.2.2. By Service
7.3.2.2.3. By Company Size
7.3.3. United Kingdom Nutraceuticals CDMO Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Dosage Form
7.3.3.2.2. By Service
7.3.3.2.3. By Company Size
7.3.4. Italy Nutraceuticals CDMO Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Dosage Form
7.3.4.2.2. By Service
7.3.4.2.3. By Company Size
7.3.5. Spain Nutraceuticals CDMO Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Dosage Form
7.3.5.2.2. By Service
7.3.5.2.3. By Company Size
8. Asia-Pacific Nutraceuticals CDMO Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Dosage Form
8.2.2. By Service
8.2.3. By Company Size
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Nutraceuticals CDMO Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Dosage Form
8.3.1.2.2. By Service
8.3.1.2.3. By Company Size
8.3.2. India Nutraceuticals CDMO Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Dosage Form
8.3.2.2.2. By Service
8.3.2.2.3. By Company Size
8.3.3. Japan Nutraceuticals CDMO Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Dosage Form
8.3.3.2.2. By Service
8.3.3.2.3. By Company Size
8.3.4. South Korea Nutraceuticals CDMO Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Dosage Form
8.3.4.2.2. By Service
8.3.4.2.3. By Company Size
8.3.5. Australia Nutraceuticals CDMO Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Dosage Form
8.3.5.2.2. By Service
8.3.5.2.3. By Company Size
9. Middle East & Africa Nutraceuticals CDMO Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Dosage Form
9.2.2. By Service
9.2.3. By Company Size
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Nutraceuticals CDMO Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Dosage Form
9.3.1.2.2. By Service
9.3.1.2.3. By Company Size
9.3.2. UAE Nutraceuticals CDMO Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Dosage Form
9.3.2.2.2. By Service
9.3.2.2.3. By Company Size
9.3.3. South Africa Nutraceuticals CDMO Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Dosage Form
9.3.3.2.2. By Service
9.3.3.2.3. By Company Size
10. South America Nutraceuticals CDMO Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Dosage Form
10.2.2. By Service
10.2.3. By Company Size
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nutraceuticals CDMO Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Dosage Form
10.3.1.2.2. By Service
10.3.1.2.3. By Company Size
10.3.2. Colombia Nutraceuticals CDMO Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Dosage Form
10.3.2.2.2. By Service
10.3.2.2.3. By Company Size
10.3.3. Argentina Nutraceuticals CDMO Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Dosage Form
10.3.3.2.2. By Service
10.3.3.2.3. By Company Size
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Nutraceuticals CDMO Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Catalent Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Lonza Group AG
15.3. NUTRASCIENCE LABS Inc
15.4. Robinson Pharma, Inc.
15.5. Health Wright Products, Inc.
15.6. Innovations in Nutrition + Wellness
15.7. INPHARMA S.p.A.
15.8. Aenova Group
15.9. NutraPak USA
15.10. SFI Health Pty Ltd.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Nutraceuticals CDMO market report include:
  • Catalent Inc.
  • Lonza Group AG
  • NUTRASCIENCE LABS Inc
  • Robinson Pharma, Inc.
  • Health Wright Products, Inc.
  • Innovations in Nutrition + Wellness
  • INPHARMA S.p.A.
  • Aenova Group
  • NutraPak USA
  • SFI Health Pty Ltd.

Table Information

Report AttributeDetails
No. of Pages190
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 35.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 55.39 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Probiotics CDMO Service Market - Global Forecast 2025-2030 - Product Image

Probiotics CDMO Service Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Postbiotics CDMO Service Market - Global Forecast 2025-2030 - Product Image

Postbiotics CDMO Service Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2025 - Product Image

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Oral Solid Dosage CDMO Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules), Mechanism (Immediate Release, Delayed Release), Drug Potency, End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Oral Solid Dosage CDMO Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules), Mechanism (Immediate Release, Delayed Release), Drug Potency, End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 262 Pages
  • Global
From
Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Route of Administration (Topical, Transdermal), By Product, By Service, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis Report By Route of Administration (Topical, Transdermal), By Product, By Service, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 145 Pages
  • Global
From

About the Nutraceuticals CDMO Market

The Nutraceuticals CDMO market is a subset of the larger Nutraceuticals industry, which focuses on the development and production of dietary supplements and functional foods. Nutraceuticals are designed to provide health benefits beyond basic nutrition, such as weight loss. Nutraceuticals CDMOs specialize in the development and manufacturing of these products, providing services such as formulation, clinical trials, and regulatory support. Nutraceuticals CDMOs are typically contract manufacturers, meaning they provide services to other companies who are developing and marketing the products. This allows companies to outsource the development and production of their products, allowing them to focus on marketing and sales. Some companies in the Nutraceuticals CDMO market include Lonza, Patheon, and Cambrex. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.